India  

The White House hopes FDA approval of the Pfizer vaccine will open the door to more vaccine mandates around the country

Video Credit: Bleacher Report AOL - Duration: 04:20s - Published
The White House hopes FDA approval of the Pfizer vaccine will open the door to more vaccine mandates around the countryCNN’s Kaitlan Collins reports.

You Might Like


💡 newsR Knowledge: Other News Mentions

White House White House Official residence and workplace of the president of the United States

US diplomats to boycott 2022 Beijing Winter Olympics

The White House says no US diplomats will attend the games in China, over human rights concerns.
BBC Sport
Fauci Says Early Reports On Omicron Variant Are 'Encouraging' [Video]

Fauci Says Early Reports On Omicron Variant Are 'Encouraging'

Fauci Says Early Reports On Omicron Variant, Are 'Encouraging'. Dr. Anthony Fauci is reportedly optimistic about the lack of severity found in cases of the Omicron variant thus far. Fauci says more time and data are needed, though preliminary research has been optimistic. Thus far, it does not look like there's a great degree of severity to it. , Dr. Anthony Fauci, chief medical advisor to White House, via 'Newsweek' . Thus far, it does not look like there's a great degree of severity to it. , Dr. Anthony Fauci, chief medical advisor to White House, via 'Newsweek' . Though optimistic, Fauci remains cautious. We have really got to be careful before we make any determinations that it is less severe or it really doesn't cause any severe illness, comparable to Delta. , Dr. Anthony Fauci, chief medical advisor to White House, via 'Newsweek' . We have really got to be careful before we make any determinations that it is less severe or it really doesn't cause any severe illness, comparable to Delta. , Dr. Anthony Fauci, chief medical advisor to White House, via 'Newsweek' . The doctor says the Biden administration has discussed the potential to lift the recently instated travel bans on multiple nations in Africa. The doctor says the Biden administration has discussed the potential to lift the recently instated travel bans on multiple nations in Africa. Hopefully we'll be able to lift that ban in a quite reasonable period of time, Dr. Anthony Fauci, chief medical advisor to White House, via 'Newsweek' . Hopefully we'll be able to lift that ban in a quite reasonable period of time, Dr. Anthony Fauci, chief medical advisor to White House, via 'Newsweek' . We all feel very badly about the hardship that has been put on not only on South Africa but the other African countries. , Dr. Anthony Fauci, chief medical advisor to White House, via 'Newsweek' . We all feel very badly about the hardship that has been put on not only on South Africa but the other African countries. , Dr. Anthony Fauci, chief medical advisor to White House, via 'Newsweek' . Initially detected in the United States on December 1, the Omicron variant has spread quickly. Initially detected in the United States on December 1, the Omicron variant has spread quickly. The heavily mutated strain of the coronavirus has been detected in over a dozen states in America. The heavily mutated strain of the coronavirus has been detected in over a dozen states in America

Credit: Wibbitz Top Stories    Duration: 01:30Published

President Biden Restarts Tradition, Hosts Kennedy Center Honorees

President Biden resumed what had been paused for a good while in D.C. -- namely, POTUS being in attendance for the Kennedy Center Honors ... and hosting them..
TMZ.com
Young Americans Are Losing Faith in Democracy [Video]

Young Americans Are Losing Faith in Democracy

Young Americans, Are Losing Faith in Democracy. Young Americans, Are Losing Faith in Democracy. Young Americans , Are Losing Faith in Democracy. NPR News reports many young citizens of the United States are concerned about the future of the country's democracy. NPR News reports many young citizens of the United States are concerned about the future of the country's democracy. A poll conducted by the Harvard University Kennedy School's Institute of Politics shows 52% of young Americans believe US democracy is "in trouble.". A poll conducted by the Harvard University Kennedy School's Institute of Politics shows 52% of young Americans believe US democracy is "in trouble.". Merely 7% of those who participated in the study believes the democratic process in the United States is "healthy.". Merely 7% of those who participated in the study believes the democratic process in the United States is "healthy.". Nearly half of all young Republicans believe the country will experience civil war during their lifetime. Nearly half of all young Republicans believe the country will experience civil war during their lifetime. Young voters showed out in the 2020 election, propelling Joe Biden into the White House. Young voters showed out in the 2020 election, propelling Joe Biden into the White House. Nearly a year into the 79-year-old president's first term, his approval rating among young people is 46%. Nearly a year into the 79-year-old president's first term, his approval rating among young people is 46%. Last March showed a much more favorable outlook for Biden among younger citizens. 59% of them approved of his performance. The study indicates cause for concern for the mental health of the young adults of the United States. . As the COVID-19 pandemic continues onward with no end in sight, 51% of young Americans said they felt "depressed, or hopeless.". there are millions of millions of millions ...who are struggling with this on a regular basis. , Della Volpe, former advisor Biden campaign, via NPR News. there are millions of millions of millions ...who are struggling with this on a regular basis. , Della Volpe, former advisor Biden campaign, via NPR News

Credit: Wibbitz Top Stories    Duration: 01:30Published
First Case of Omicron Strain Detected in the United States [Video]

First Case of Omicron Strain Detected in the United States

First Case of , Omicron Strain, Detected in the United States. NPR News reports the first known case of the Omicron COVID-19 variant has been found in the United States. According to the Centers for Disease Control and Prevention, the strain was detected in California. According to the Centers for Disease Control and Prevention, the strain was detected in California. The individual was a traveler who returned from South Africa on November 22. , Centers for Disease Control and Prevention, statement, via NPR News. The case was confirmed by the health departments of San Francisco and the state of California. The case was confirmed by the health departments of San Francisco and the state of California. The individual, who was fully vaccinated... had mild symptoms that are improving, Centers for Disease Control and Prevention, statement, via NPR News. Dr. Anthony Fauci says the infected person isn't believed to have received a booster shot. Dr. Anthony Fauci says the infected person isn't believed to have received a booster shot. Cases of the Omicron strain had been previously identified throughout Europe to the Middle East. Cases of the Omicron strain had been previously identified throughout Europe to the Middle East. The strain was first detected in South Africa. Mutations of the variant have been a cause of concern for the World Health Organization (WHO). The WHO says these mutations "may be associated with immune escape potential and higher transmissibility.". Despite the frustrations of the ongoing pandemic, Dr. Fauci remains cautiously optimistic. Despite the frustrations of the ongoing pandemic, Dr. Fauci remains cautiously optimistic. There's no doubt that this will end, I promise you that, this will end. , Dr. Anthony Fauci, chief medical adviser for the White House, via NPR News. There's no doubt that this will end, I promise you that, this will end. , Dr. Anthony Fauci, chief medical adviser for the White House, via NPR News

Credit: Wibbitz Top Stories    Duration: 01:30Published

Food and Drug Administration Food and Drug Administration Agency of the US Department of Health and Human Services

FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill [Video]

FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill

FDA Advisers Narrowly Endorse , Merck’s COVID Antiviral Pill. On Nov. 30, the FDA's Antimicrobial Drugs Advisory Committee voted to endorse Merck's molnupiravir pill for use in treating COVID-19 in high-risk adults. On Nov. 30, the FDA's Antimicrobial Drugs Advisory Committee voted to endorse Merck's molnupiravir pill for use in treating COVID-19 in high-risk adults. The vote was 13-10. The panel's decision could prompt the agency to grant Merck emergency use authorization, which the U.K. has already done. CBS News reports the Biden administration has already bought about 3.1 million courses of the treatment, which is given to patients over five days. CBS News reports the Biden administration has already bought about 3.1 million courses of the treatment, which is given to patients over five days. This is the first opportunity that an oral outpatient medication for mildly symptomatic to moderate symptomatic persons would be available, Dr. W. David Hardy, a scientist at Charles Drew University School of Medicine and Science and panel member, via CBS News. Those in opposition debated the rare risk that the drug, which relies on triggering mutations of the virus, might unleash a new variant. Even if the probability is very low, one in 10,000 to one in 100,000, that this drug would induce an escape mutant for which the vaccines we have do not cover, that would be catastrophic for the whole world actually, Dr. James Hildreth, one of the panel's advisers, via CBS News. CBS News reports Merck admitted it did not have the data to accurately estimate that risk, but no one who took the pills appeared to be infectious. Additionally, Merck's most recent trial data revealed a 30% efficacy rate as opposed to its initial claim of reducing the risk of hospitalization or death by 50%. Additionally, Merck's most recent trial data revealed a 30% efficacy rate as opposed to its initial claim of reducing the risk of hospitalization or death by 50%

Credit: Wibbitz Top Stories    Duration: 01:30Published
Vaccine Expert: Everyone on FDA panel would vaccinate their own child [Video]

Vaccine Expert: Everyone on FDA panel would vaccinate their own child

Dr. Paul Offit, pediatrician, vaccine pioneer and author of “You Bet Your Life,” explains the risk inherent in every major medical breakthrough

Credit: Bleacher Report AOL    Duration: 10:12Published
FDA authorizes Pfizer's Covid-19 vaccine for children 5 to 11 [Video]

FDA authorizes Pfizer's Covid-19 vaccine for children 5 to 11

CNN’s Nick Watt reports.

Credit: Bleacher Report AOL    Duration: 02:49Published
The American Academy of Pediatrics welcomes FDA's decision to authorize Pfizer's Covid-19 vaccine for children 5 to 11 [Video]

The American Academy of Pediatrics welcomes FDA's decision to authorize Pfizer's Covid-19 vaccine for children 5 to 11

Dr. Lee Savio Beers discusses with CNN’s Jake Tapper.

Credit: Bleacher Report AOL    Duration: 04:18Published

Pfizer Pfizer American multinational pharmaceutical corporation

Pfizer Says Its Booster Provides Protection Against Omicron Variant [Video]

Pfizer Says Its Booster Provides Protection Against Omicron Variant

Pfizer Says Its Booster Provides , Protection Against Omicron Variant. Pfizer Says Its Booster Provides , Protection Against Omicron Variant. NBC News reports officials with Pfizer-BioNTech say a booster dose of the companies' coronavirus vaccine supplies ample protection against the new Omicron variant. NBC News reports officials with Pfizer-BioNTech say a booster dose of the companies' coronavirus vaccine supplies ample protection against the new Omicron variant. Research shows their booster shot offers a similar degree of protection as two regular doses of their vaccine does against the original COVID-19 strain. Three doses against Omicron are almost equivalent to the two doses effectiveness we had against the... original variant. , Albert Bourla, CEO Pfizer, via NBC News. Lab tests suggest two doses of the Pfizer-BioNTech vaccine experience a 25-fold drop in efficacy when matched against the Omicron strain. An independent study showed the Pfizer vaccine's regular dose experienced a forty-fold reduction in neutralizing antibodies. . An independent study showed the Pfizer vaccine's regular dose experienced a forty-fold reduction in neutralizing antibodies. . Officials say these results are preliminary. More data will be necessary. Initially found in South Africa, the heavily-mutated Omicron variant is quickly spreading around the globe. Initially found in South Africa, the heavily-mutated Omicron variant is quickly spreading around the globe. Pfizer says it has begun work on an Omicron-specific vaccine. According to officials it could be ready in around 100 days. If we need a new vaccine, those tests are telling me we will be able to have a very good one if we need one. , Albert Bourla, CEO Pfizer, via NBC News. The current booster will maintain protection, but if we need one, we will make one and we will have it by March. , Albert Bourla, CEO Pfizer, via NBC News . The current booster will maintain protection, but if we need one, we will make one and we will have it by March. , Albert Bourla, CEO Pfizer, via NBC News

Credit: Wibbitz Top Stories    Duration: 01:30Published

Three doses of Pfizer vaccine can 'neutralise' Omicron variant, lab test shows

Three shots of the Pfizer/BioNTech COVID-19 vaccine has been shown to generate a neutralising effect against the new Omicron variant in a laboratory test.
Sky News

'Just do it': Margaret Keenan's message one year after receiving first COVID jab

The grandmother who made history when she got the Pfizer COVID jab exactly a year ago has urged anyone still to get vaccinated to "just do it" and help save..
Sky News

Pfizer vaccine may be up to 40 times less effective against Omicron, first lab tests in South Africa suggest

The Pfizer vaccine may be up to 40 times less effective against Omicron than the original COVID strain, the first lab tests on the new variant in South Africa..
Sky News

Antibodies from Pfizer vaccine may be up to 40 times less effective against Omicron, first lab tests suggest

The Pfizer vaccine may be up to 40 times less effective against Omicron than the original COVID strain, the first lab tests on the new variant in South Africa..
Sky News

Kaitlan Collins Kaitlan Collins American journalist (born 1992)

Biden sells his infrastructure law at run-down New Hampshire bridge [Video]

Biden sells his infrastructure law at run-down New Hampshire bridge

CNN’s Kaitlan Collins reports.

Credit: Bleacher Report AOL    Duration: 03:02Published
Poll: GOP holds 10-point lead among registered voters [Video]

Poll: GOP holds 10-point lead among registered voters

CNN’s Kaitlin Collins discusses a recent ABC/Washington Post poll of registered voters that shows Republicans holding a larger advantage over Democrats in 2022 House races.

Credit: Bleacher Report AOL    Duration: 01:28Published
President Biden argues his Build Back Better agenda will ease inflationary pressures [Video]

President Biden argues his Build Back Better agenda will ease inflationary pressures

CNN’s Kaitlan Collins reports.

Credit: Bleacher Report AOL    Duration: 01:16Published
Biden urges House Dems to pass bipartisan infrastructure bill and his Build Back Better plan - but will they? [Video]

Biden urges House Dems to pass bipartisan infrastructure bill and his Build Back Better plan - but will they?

CNN’s Kaitlan Collins reports.

Credit: Bleacher Report AOL    Duration: 03:33Published

Related videos from verified sources

Will the FDA approval change your mind about the vaccine? p4 [Video]

Will the FDA approval change your mind about the vaccine? p4

Rhori Johnston is joined by Dr. Aimalohi Ahonkhai to discuss the FDA's approval of the Pfizer vaccine, and answer questions about vaccine hesitancy.

Credit: NewsChannel 5 Nashville     Duration: 17:17Published
Will the FDA approval change your mind about the vaccine? p2 [Video]

Will the FDA approval change your mind about the vaccine? p2

Rhori Johnston is joined by Dr. Aimalohi Ahonkhai to discuss the FDA's approval of the Pfizer vaccine, and answer questions about vaccine hesitancy.

Credit: NewsChannel 5 Nashville     Duration: 10:26Published
Will the FDA approval change your mind about the vaccine? part 4 [Video]

Will the FDA approval change your mind about the vaccine? part 4

Rhori Johnston is joined by Dr. Aimalohi Ahonkhai to discuss the FDA's approval of the Pfizer vaccine, and answer questions about vaccine hesitancy.

Credit: NewsChannel 5 Nashville     Duration: 08:21Published